A semi-quantitative visual lateral flow immunoassay for SARS-CoV-2 antibody detection for the follow-up of immune response to vaccination or recovery

Simone Cavalera,Fabio Di Nardo,Thea Serra,Valentina Testa,Claudio Baggiani,Sergio Rosati,Barbara Colitti,Ludovica Brienza,Irene Colasanto,Chiara Nogarol,Domenico Cosseddu,Cristina Guiotto,Laura Anfossi

DOI: https://doi.org/10.1039/d3tb02895j

IF: 7.571

2024-01-27

Journal of Materials Chemistry B

Abstract:The lateral flow immunoassay (LFIA) technique is largely employed for the point-of-care detection of antibodies especially for revealing the immune response in serum. Visual LFIAs usually provide the qualitative yes/no detection of antibodies, while quantification requires some equipment, making the assay more expensive and complicated. To achieve the visual semi-quantification, the aligningment of several lines (made of the same antigen) along a LFIA strip, and the numbering of the reacting lines has been proposed as a strategy to correlate with the quantity of some biomarkers in serum. Here, we designed the first semiquantitative LFIA for detecting antibodies and applied it to classify the immuneresponse to SARS-CoV-2 raised by vaccination or natural infection. We used a recombinant spike receptor-binding domain (RBD) as the specific capture reagent to draw two test lines. The detection reagent was selected among three possible ligands able to bind to anti-spike human antibodies: the same RBD, staphylococcal protein A, and anti-human immunoglobulins G antibodies. The most convenient detector, adsorbed on gold nanoparticles, was chosen basing on the highest correlation with the antibody titre of 171 human sera, measured by a reference serological method, and was the RBD (Spearman's rho=0.84). Incorporated into the semiquantitative LFIA, it confirmed the ability of discriminating high- and low-titre samples and of classifying them into two classes (Dunn's test, P<0.05). The proposed approach enabled the semiquantification of the immuneresponse to SARS-CoV-2 by the unaided eye observation, thus overcoming the requirement of costly and complicated equipment, and represents a general strategy for the development of semiquantitative serological LFIAs.

materials science, biomaterials